Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to assess the efficacy of a synbiotic blend on exercise performance and other exercise parameters in trained adult cyclists. It is hypothesized that those taking the synbiotic blend will have improved endurance exercise performance. The primary objective is to assess the impact of a synbiotic on 20km distance trial performance in 36 cyclists. Secondary objectives include assessing the impact of the synbiotic on exercise metabolism, body composition, gastrointestinal and immune health.


Clinical Trial Description

The goal of this randomized double-blinded clinical trial is to evaluate the potential beneficial effects of a synbiotic formulation on exercise performance in trained adult cyclists. The main questions it aims to answer are related to the Synbiotic effects on: - Cycling performance - Exercise metabolism - Gastrointestinal health - Immune system - Body composition - Fecal Short Chain Fatty Acids (SCFAs) - Fecal microbiome composition Participants will be recruited and, if consenting and eligible, will undergo the initial pre-testing phase for baseline assessment (4 on-site visits). Then, they will be randomized to receive the synbiotic or placebo and instructed to consume one sachet daily for 42 consecutive days. After 4-5 weeks of intervention (Day 33), post-testing phase will start, and participants will be asked to return to the site to perform post testing assessments (over 4 on-site visits). Study visits will occur as follows, V1 (Day -9), V2 (Day -6), V3 (Day -3), V4 (Day 0), V5 (Day 33), V6 (Day 36), V7 (Day 39), and V8 (Day 42). Researchers will compare the assessed outcomes to baseline in each group and evaluate the difference between groups following the synbiotic consumption to highlight any statistically and clinically relevant observations. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06300060
Study type Interventional
Source University of Calgary
Contact
Status Active, not recruiting
Phase N/A
Start date April 9, 2024
Completion date February 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04588142 - Impact of Probiotic Supplementation on Exercise Endurance Among Non-elite Athletes N/A
Completed NCT02804243 - The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure N/A
Enrolling by invitation NCT04941456 - Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy? N/A